晚期心力衰竭:一种当代的方法
Kyeong-Hyeon Chun1, Seok-Min Kang2
1Division of Cardiology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
The Korean journal of internal medicine
|June 27, 2023
概括
高级心力衰竭 (HF) 管理包括及时干预,如心脏移植或机械循环支持 (MCS). 新的药物,设备和MCS选择正在扩大严重HF患者的治疗可能性.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
背景情况:
- 晚期心力衰竭 (HF) 的特点是,尽管采取了最佳疗法,但仍存在持续的严重症状.
- 患者需要先进的治疗方法,如心脏移植或机械循环支持 (MCS).
研究的目的:
- 审查先进心力衰竭 (HF) 的现有和新兴治疗方案.
- 突出高级HF患者多学科管理计划的重要性.
主要方法:
- 审查当前的医疗,手术和设备治疗先进的HF.
- 讨论新型治疗方法,包括无otropic 药物,置换疗法,心脏再同步疗法,植入式心脏转换器-除器和跨导管边缘到边缘修复.
- 在后期阶段考虑心脏移植和机械循环支持 (MCS).
主要成果:
- 心脏再同步疗法在特定的HF患者中具有降低射出小部分的益处.
- 跨导管边缘到边缘的修复可能会在某些情况下延迟移植或长期MCS的需要.
- 最近药物,设备和MCS方面的进展扩大了治疗选择.
结论:
- 跨学科的方法对于管理先进的HF至关重要.
- 治疗方法的持续进步为患有晚期心力衰竭的患者提供了更广泛的选择.
- 需要对在晚期HF接受新药物治疗的可植入心脏转换器-除器进行进一步的研究.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
Heart Failure IV: Classification and Diagnostic Evaluation
20
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
20
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
Heart Failure VII: Nursing Interventions
111
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
111
Cardiomyopathy V: Interprofessional Care
18
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
18


